Marksans Pharma Limited (MARKSANS.NS) NSE

244.05

+2.85999(+1.19%)

Updated at June 03 01:30PM

Currency In INR

Valuation

Market Cap71.11B
Enterprise Value64.65B
P/E Ratio26.54
PEG Ratio2.69
Price/Sales Ratio3.76
Price/Book Ratio3.67
Enterprise/Revenue3.54
Enterprise/EBITDA16.12

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.14
Operating Margin0.17

Management Effectiveness

Return On Assets0.11
Return On Equity0.16

Income Statement

Revenue29.51B
Revenue/Share65.14
Gross Profit11.57B
EBITDA6.03B
Net Income4.18B
Diluted EPS9.22

Balance Sheet

Total Cash9.9B
Total Cash/Share21.85
Total Debt3.43B
Total Debt/Equity0.11
Current Ratio5.17
Book Value Per Share67.39

Price History

52-Week Change-6.32
52-Week High270.7
52-Week Low155
Moving Average 50 Days193.62
Moving Average 200 Days181.56

Statistics

Average Volume2.33M
Shares Outstanding453.16M
% Held by Institutions0.14

Dividend And Splits

Trailing Annual Dividend Rate0.8
Trailing Annual Dividend Yield0.33
Payout Ratio0.09
Last Split Factor10:1
Last Split DateMarch 11, 2008